[go: up one dir, main page]

CU20090141A7 - Compuestos 2-amino pirimidina - Google Patents

Compuestos 2-amino pirimidina

Info

Publication number
CU20090141A7
CU20090141A7 CU20090141A CU20090141A CU20090141A7 CU 20090141 A7 CU20090141 A7 CU 20090141A7 CU 20090141 A CU20090141 A CU 20090141A CU 20090141 A CU20090141 A CU 20090141A CU 20090141 A7 CU20090141 A7 CU 20090141A7
Authority
CU
Cuba
Prior art keywords
pyrimidine compounds
amino pyrimidine
amino
compounds
pyrimidine
Prior art date
Application number
CU20090141A
Other languages
English (en)
Inventor
Michael Bennett
Luke Zehnder
Sacha Ninkovic
Pei-Pei Kung
Jerry Meng
Buwen Huang
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CU20090141A7 publication Critical patent/CU20090141A7/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CU20090141A 2007-02-06 2008-01-25 Compuestos 2-amino pirimidina CU20090141A7 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88843307P 2007-02-06 2007-02-06
US2066108P 2008-01-11 2008-01-11
PCT/IB2008/000200 WO2008096218A1 (en) 2007-02-06 2008-01-25 2-amin0-5, 7-dihydr0-6h- pyrrolo [3, 4-d] pyrimidine derivatives as hsp-90 inhibitors for treating cancer

Publications (1)

Publication Number Publication Date
CU20090141A7 true CU20090141A7 (es) 2011-04-26

Family

ID=39367692

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20090141A CU20090141A7 (es) 2007-02-06 2008-01-25 Compuestos 2-amino pirimidina

Country Status (22)

Country Link
US (1) US20100093696A1 (es)
EP (1) EP2118111B1 (es)
JP (1) JP4523073B2 (es)
KR (1) KR20090116789A (es)
AP (1) AP2009004954A0 (es)
AT (1) ATE502944T1 (es)
AU (1) AU2008212645A1 (es)
BR (1) BRPI0807165A2 (es)
CA (1) CA2677365A1 (es)
CO (1) CO6220971A2 (es)
CR (1) CR10963A (es)
CU (1) CU20090141A7 (es)
DE (1) DE602008005715D1 (es)
DO (1) DOP2009000200A (es)
EA (1) EA200970669A1 (es)
EC (1) ECSP099565A (es)
IL (1) IL200169A0 (es)
MA (1) MA31170B1 (es)
MX (1) MX2009008386A (es)
NI (1) NI200900155A (es)
TN (1) TN2009000329A1 (es)
WO (1) WO2008096218A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011530580A (ja) * 2008-08-13 2011-12-22 ファイザー・インク 強力なhsp−90阻害剤としての2−アミノピリミジン化合物
GB0907284D0 (en) 2009-04-28 2009-06-10 Queen Mary & Westfield College Compounds for inducing cellular apoptosis
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
CN102822169A (zh) 2009-12-30 2012-12-12 艾科尔公司 取代的萘基-嘧啶化合物
EP2752201A1 (en) * 2013-01-04 2014-07-09 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. C-terminal HSP90 inhibitors to treat pituitary adenomas
US9447026B2 (en) 2013-03-14 2016-09-20 Kalyra Pharmaceuticals, Inc. Bicyclic analgesic compounds
CN105814013A (zh) 2013-12-12 2016-07-27 卡利拉制药公司 双环烷基化合物及合成
CA2942144C (en) 2014-03-07 2023-08-22 Kalyra Pharmaceuticals, Inc. Propellane derivates and synthesis
JP6779867B2 (ja) 2014-06-13 2020-11-04 ユマ セラピューティクス,インコーポレーテッド ピリミジン化合物およびその使用方法
JP6833677B2 (ja) 2014-09-17 2021-02-24 リキュリウム アイピー ホールディングス リミテッド ライアビリティー カンパニー 二環式化合物
US10227029B2 (en) * 2015-08-07 2019-03-12 Kawasaki Jukogyo Kabushiki Kaisha Container holder attached to utility vehicle
KR20200018440A (ko) 2017-05-15 2020-02-19 리커리엄 아이피 홀딩스, 엘엘씨 진통제 화합물
WO2020243457A1 (en) * 2019-05-29 2020-12-03 Viogen Biosciences, Llc Compounds and therapeutic uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
RS50444B (sr) 2000-02-15 2010-03-02 Sugen Inc. Inhibitori 2-indolinon protein kinaze supstituisani pirolom
EP1470121B1 (en) * 2002-01-23 2012-07-11 Bayer HealthCare LLC Pyrimidine derivatives as rho-kinase inhibitors
US7312330B2 (en) * 2003-12-24 2007-12-25 Renovis, Inc. Bicycloheteroarylamine compounds as ion channel ligands and uses thereof
CA2602257A1 (en) * 2005-03-30 2006-10-05 Conforma Therapeutics Corporation Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors

Also Published As

Publication number Publication date
MX2009008386A (es) 2009-10-16
DE602008005715D1 (de) 2011-05-05
KR20090116789A (ko) 2009-11-11
EA200970669A1 (ru) 2010-02-26
CO6220971A2 (es) 2010-11-19
NI200900155A (es) 2010-06-30
JP4523073B2 (ja) 2010-08-11
ECSP099565A (es) 2009-09-29
BRPI0807165A2 (pt) 2014-05-06
WO2008096218A1 (en) 2008-08-14
CR10963A (es) 2009-08-27
DOP2009000200A (es) 2009-09-15
EP2118111A1 (en) 2009-11-18
AU2008212645A1 (en) 2008-08-14
AP2009004954A0 (en) 2009-08-31
JP2010518066A (ja) 2010-05-27
TN2009000329A1 (fr) 2010-12-31
ATE502944T1 (de) 2011-04-15
US20100093696A1 (en) 2010-04-15
CA2677365A1 (en) 2008-08-14
IL200169A0 (en) 2010-04-15
EP2118111B1 (en) 2011-03-23
MA31170B1 (fr) 2010-02-01

Similar Documents

Publication Publication Date Title
CU20090141A7 (es) Compuestos 2-amino pirimidina
DK2154967T3 (da) Pyrimidinderivater
BRPI0907435A2 (pt) Derivados de 5-flúor pirimidina
DK2046740T3 (da) Forbindelser med CRTH2-antagonistisk virkning
BRPI0813500A2 (pt) Compostos antivirais
BRPI0821086A2 (pt) Compostos inseticidas
BRPI0815042A2 (pt) Compostos de pirazol
BRPI0811280A2 (pt) Compostos amino-heterocíclicos
DK2054394T3 (da) Piperazinforbindelser med herbicid virkning
DK2185567T3 (da) Substituerede bicyclolactam-forbindelser
DK3354267T3 (da) Stabiliseret sulforaphan
BRPI0916233A2 (pt) compostos heterocíclicos antivirais
EP2233838A4 (en) COOKER
BRPI0811264A2 (pt) Compostos
DK2132326T3 (da) Fremgangsmåder
BRPI0821349A2 (pt) compostos antivirais heterocíclicos
BRPI0920496A2 (pt) derivados substituídos de pirimidina etriazina
BRPI0811115A2 (pt) Compostos de heteroarilamida pirimidona
BRPI0814424A2 (pt) Compostos heterociclila
BRPI0809996A2 (pt) Compostos
BRPI0916679A2 (pt) 5-alquinil-pirimidinas
BRPI0924121A2 (pt) compostos antivirais heterocíclicos
SI2188291T1 (sl) Zliti biciklični pirimidini
BRPI0820779A2 (pt) Derivados de 4-amino-pirimidina
BRPI0811597A2 (pt) compostos de arilamida pirimidona